This inventor holds 1 USPTO granted patent. Top assignee: University of Houston System. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Stanley J Kleis in Bioreactor Technology
Introduction
Stanley J Kleis is an accomplished inventor based in Houston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of bioreactor systems. His innovative work focuses on enhancing cell culture techniques, which are crucial for various applications in research and medicine.
Latest Patents
Stanley J Kleis holds a patent for a "Method and apparatus for a miniature bioreactor system for long-term cell culture." This invention describes a bioreactor and method that allows for continuous and simultaneous short, moderate, or long-term cell culturing of one or more cell types or tissues in a laminar flow configuration. The bioreactor supports at least two laminar flow zones, which are isolated by laminar flow without the need for physical barriers between the zones. This technology is ideally suited for studying the response of cell cultures to various stressors, including pharmaceuticals and pathogens. The bioreactors also facilitate periodic cell harvesting and medium processing for secreted cellular components. Stanley J Kleis has 1 patent to his name.
Career Highlights
Stanley J Kleis is affiliated with the University of Houston System, where he continues to advance research in bioreactor technology. His work has implications for both academic research and practical applications in the biotechnology industry.
Collaborations
Some of his notable coworkers include Sandra K Geffert and Steve R Gonda, who have collaborated with him on various projects related to cell culture and bioreactor systems.
Conclusion
Stanley J Kleis is a pioneering inventor whose work in bioreactor technology has the potential to transform cell culture practices in research and medicine. His innovative approaches contribute significantly to the advancement of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
